Our Team

Big goals in the big apple

We come from different backgrounds, but we share the same belief: that science can change the world for the better. We exist to deliver life-saving cancer therapies through breakthroughs in drug discovery.

Our bios recount our academic credentials, but there’s a lot more to us. Our individual experiences shape who we are as a team, and together we’re passionate about making a difference.

We are supported by a premier group of investors and board members with a proven track record of building successful biotechnology companies. Our founders and scientific advisors are renowned for their seminal discoveries in cancer biology.

Hyeseok Shim, Ph.D.

Senior Scientist, Biology

Aaron Phillips, Ph.D.

Scientist II, Biology

Rachel Zolot Schwartz, MBA

VP, Business Development & Commercial

Akanksha Verma, Ph.D.

Scientist II, Computational Biology

Rick Tourdot, Ph.D.

Scientist II, Computational Biology

Martha Rutkowski

Executive Assistant/Office Manager

Alan Chiu, Ph.D.

Scientist I, Biology

Charles Hugh-jones, M.D., FRCP

Chief Executive Officer

Christina Eng, Ph.D.

Senior Director, Biology

Michael Arensman, Ph.D.

Senior Scientist, Biology

Jonathan Havel, Ph.D.

Scientist II, Immunology

Sarah Bettigole, Ph.D.

Director, Immunology

Nazario Bosco, Ph.D.

Senior Scientist, Biology

Reka Letso, Ph.D.

Scientist II & Lab Manager

Diane Tager, MBA

VP, Strategy and Operations

Michael Su, Ph.D.

Chief Scientific Officer

Bernardo Tavora, Ph.D.

Senior Scientist, Immunology

Rumin Zhang, Ph.D.

VP, Biochemistry

Zafi Avnur, Ph.D.

Chief Scientific Officer
Quark Venture

Samuel Bakhoum, M.D., Ph.D.

Assistant Member
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center

Luc Dochez, Pharm.D.

DROIA Oncology Ventures

Sandi Peterson, Chair

Operating Partner
Clayton, Dubilier & Rice

Amy Schulman

Managing Partner
Polaris Partners

Stefan Vitorovic

Co-Founder and Managing Director
Vida Ventures

Samuel Bakhoum, M.D., Ph.D.

Assistant Member
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center

David Baltimore, Ph.D.

President Emeritus and Distinguished Professor of Biology
California Institute of Technology

Lewis Cantley, Ph.D.

Meyer Director
Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College

Hans Clevers, M.D., Ph.D.

Professor, Molecular Genetics
University Medical Center Utrecht

Duane Compton, Ph.D.

Geisel School of Medicine, Dartmouth College

Olivier Elemento, Ph.D.

Director of the Englander Institute for Precision Medicine
Weill Cornell Medicine

Gerard Evan, Ph.D.

Sir William Dunn Professor and Chair
Department of Biochemistry, University of Cambridge

Tarun Kapoor, Ph.D.

PELS Family Professor
Rockefeller University

David Pellman, M.D.

Margaret M. Dyson Professor of Pediatric Oncology
Dana-Farber Cancer Institute

Harold Varmus, M.D.

Lewis Thomas University Professor, Medicine
Meyer Cancer Center, Weill Cornell Medicine

Karen Vousden, Ph.D.

Chief Scientist
Cancer Research UK